The News

Euclyd Raises $230 Million For A Non-GPU Inference Architecture

On September 14, 2026, Dutch AI chip startup Euclyd announced it had raised more than €200 million, roughly $230 million, in a Series A round co-led by Samsung, Somerset Capital Partners, the EQT-managed Scaleup Europe Fund, and Innovation Industries.

The Eindhoven-based company is developing an inference architecture that departs from conventional GPUs, combining custom compute, memory design, and data-center systems. It is not designing a faster graphics processor; it is rearranging the relationship between the processor and the memory feeding it.

Credibility came with the round. Former ASML CEO Peter Wennink is joining Euclyd as chairman, which matters in a country whose semiconductor reputation rests largely on that company.

Euclyd's chief executive was direct about why Samsung's involvement counts beyond the cheque, noting that Samsung can help in more ways than money as one of the world's biggest memory manufacturers.

Gold has nearly doubled in a year. But a Barron's top 1% hedge fund manager says buying gold is the worst way to profit.

Instead, he's developed a strategy that lets you "skim" cash from gold's big moves — up or down — without owning any gold at all.

His followers have already had the chance to collect $42,920.

The Company Behind It

A Startup Selling Both Boxes And Blueprints

Euclyd is targeting inference specifically, meaning the work of running trained models rather than building them, which is where the bulk of ongoing AI spending now sits.

Its commercial model has two paths. The company plans to sell hardware and physical rack systems to enterprise customers who want secure self-hosted AI inference, and to license its intellectual property to companies that want to develop their own chips based on existing technology.

The market it is entering is unforgiving. Nvidia's dominance rests on far more than GPUs, with its software ecosystem, networking technology, developer base, and supply relationships creating formidable barriers for challengers.

Why This Matters Financially

The Investor Is Also The Supplier

Samsung's participation is strategic rather than financial. A memory manufacturer backing an architecture built around memory gains both a design partner and a potential customer for high-bandwidth memory, which is the component in shortest supply.

The IP licensing path is the clever hedge. Selling hardware means competing with Nvidia directly, but licensing designs means earning from companies that build their own chips, so Euclyd can profit even from rivals' silicon.

Energy is the commercial argument. Euclyd says its systems will reduce the energy needs and costs of AI data center infrastructure, and with power now the binding constraint on data center construction, efficiency has become a purchasing criterion rather than a nice-to-have.

Limits and Uncertainty

The Catch: Nothing Has Run At Scale Yet

Euclyd's systems have yet to be proven at scale in commercial deployments. A Series A funds development, not delivery, and the gap between a promising architecture and a rack running production workloads has consumed many well-funded chip startups.

The competitive field is also crowded with better-capitalized attempts. Several inference-specialist companies have raised far larger sums this year, Nvidia keeps improving performance per watt on its own hardware, and switching costs remain the real moat, since customers must rewrite software to leave the GPU ecosystem regardless of how good the alternative is. European backing helps with capital but not with the developer base a rival platform needs.

The round matters because it shows investors treating memory bandwidth, not raw compute, as the limit on AI economics, and a memory giant funding that thesis directly. The real impact depends on whether Euclyd ships systems that work at production scale, and whether enterprises will rewrite software for a chip that is cheaper to run.

Disclosure: This content is for educational and informational purposes only and does not constitute investment advice or recommendations. You should always conduct your own research or consult a qualified financial advisor before making investment decisions.